NUSB vs CURE

Comparison between NUVEEN ULTRA SHORT INCOME ETF (NUSB, ETF) and DIREXION DAILY HEALTHCARE BULL 3X SHARES (CURE, ETF).

NUSB vs CURE - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	NUSB(ETF)	CURE(ETF)
Net Assets	$157M	$157M
Expense Ratio	0.17%	N/A
Max Drawdown	0.61%	69.19%
Sharpe Ratio	1.41	0.79
5Y Beta	0.00	1.38
P/E Ratio	N/A	28.04
Forward P/E	N/A	18.09
5Y Dividends CAGR	N/A	63.21%
5Y EPS CAGR	N/A	12.58%
Debt to Equity	N/A	53.58%
P/S Ratio	N/A	1.48
P/B Ratio	N/A	4.58

Net Assets

Winner

NUSB

$157M

CURE

$157M

Expense Ratio

NUSB

0.17%

CURE

N/A

Max Drawdown

Winner

NUSB

0.61%

CURE

69.19%

Sharpe Ratio

Winner

NUSB

1.41

CURE

0.79

5Y Beta

Winner

NUSB

0.00

CURE

1.38

P/E Ratio

NUSB

N/A

CURE

28.04

Forward P/E

NUSB

N/A

CURE

18.09

5Y Dividends CAGR

NUSB

N/A

CURE

63.21%

5Y EPS CAGR

NUSB

N/A

CURE

12.58%

Debt to Equity

NUSB

N/A

CURE

53.58%

P/S Ratio

NUSB

N/A

CURE

1.48

P/B Ratio

NUSB

N/A

CURE

4.58

NUSB vs CURE - Historical Returns

Returns include dividend reinvestment.

Period	NUSB	CURE
1 month	+0.30%	+22.71%
3 months	+0.86%	-2.64%
6 months	+1.86%	+3.17%
1 year	+4.30%	+35.83%
5 years(CAGR)	N/A	+2.35%
10 years(CAGR)	N/A	+13.12%
Max(CAGR)	+4.79%	+23.37%

NUSB

+0.30%

Winner

CURE

+22.71%

Winner

NUSB

+0.86%

CURE

-2.64%

NUSB

+1.86%

Winner

CURE

+3.17%

NUSB

+4.30%

Winner

CURE

+35.83%

5Y(CAGR)

NUSB

N/A

CURE

+2.35%

10Y(CAGR)

NUSB

N/A

CURE

+13.12%

Max(CAGR)

NUSB

+4.79%

Winner

CURE

+23.37%

NUSB vs CURE - Annual Returns (2011 - 2026)

Returns include dividend reinvestment.

Year	NUSB	CURE
2026	+1.54%	-7.73%
2025	+4.69%	+22.87%
2024	+4.50%	-12.90%
2023	N/A	-8.46%
2022	N/A	-17.91%
2021	N/A	+90.55%
2020	N/A	+4.13%
2019	N/A	+62.36%
2018	N/A	-0.75%
2017	N/A	+62.77%
2016	N/A	-12.42%
2015	N/A	+6.24%
2014	N/A	+83.03%
2013	N/A	+153.15%
2012	N/A	+45.79%
2011	N/A	-9.68%

NUSB vs CURE Drawdown Comparison

The maximum drawdown for NUSB was -0.16%, occurring on Apr 10, 2025. Recovery took 12 trading sessions.

The maximum drawdown for CURE was -69.19%, occurring on Mar 23, 2020. Recovery took 242 trading sessions.

The current CURE drawdown is -25.85%.

Rank	NUSB	CURE
#1	-0.16% Apr 1, 2025 - Apr 17, 2025	-69.19% Jan 22, 2020 - Jan 6, 2021
#2	-0.06% Mar 9, 2026 - Mar 23, 2026	-52.25% Apr 8, 2022 - Aug 7, 2025
#3	-0.06% Jun 30, 2025 - Jul 3, 2025	-48.54% Jul 20, 2015 - Jun 22, 2017
#4	-0.04% Mar 11, 2024 - Mar 19, 2024	-44.44% Jul 1, 2011 - Mar 15, 2012
#5	-0.04% Apr 4, 2024 - Apr 15, 2024	-42.27% Oct 1, 2018 - Nov 27, 2019
#6	-0.04% Oct 2, 2024 - Oct 11, 2024	-36.35% Jan 26, 2018 - Sep 13, 2018
#7	-0.04% Jul 3, 2025 - Jul 11, 2025	-29.28% Dec 30, 2021 - Apr 8, 2022
#8	-0.04% Mar 25, 2026 - Mar 30, 2026	-22.89% Aug 17, 2021 - Dec 15, 2021
#9	-0.04% Jul 14, 2025 - Jul 18, 2025	-22.59% Sep 24, 2014 - Oct 28, 2014
#10	-0.04% Oct 21, 2024 - Oct 25, 2024	-19.78% Mar 4, 2014 - Jun 19, 2014
#11	-0.04% Sep 8, 2025 - Sep 12, 2025	-19.31% Oct 17, 2012 - Jan 9, 2013
#12	-0.04% May 27, 2025 - May 30, 2025	-19.31% Jan 20, 2021 - Apr 15, 2021
#13	-0.02% Feb 27, 2026 - Mar 6, 2026	-17.38% Apr 2, 2012 - Jun 29, 2012
#14	-0.02% Aug 2, 2024 - Aug 9, 2024	-15.49% May 28, 2013 - Jul 12, 2013
#15	-0.02% Jan 3, 2025 - Jan 8, 2025	-14.96% Dec 8, 2014 - Jan 22, 2015

Correlation

Correlation between NUSB and CURE is -0.42 which considered as a weak negative correlation - the stocks show a slight tendency to move in opposite directions.

-0.42

-101

Dividend Comparison (2011 - 2026)

NUSB vs CURE dividend yield comparison.

Year	NUSB	CURE
2026	1.63%	0.27%
2025	4.51%	1.12%
2024	3.61%	1.17%
2023	0.00%	2.02%
2022	0.00%	0.38%
2021	0.00%	0.02%
2020	0.00%	0.17%
2019	0.00%	0.40%
2018	0.00%	0.70%
2017	0.00%	0.18%
2013	0.00%	1.24%
2012	0.00%	0.03%
2011	0.00%	2.10%